{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:32:13Z","timestamp":1787164333165,"version":"build-2736575974"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011002","name":"National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.peptides.2019.170210","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T20:15:54Z","timestamp":1574712954000},"page":"170210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The globus pallidus as a target for neuropeptides and endocannabinoids participating in central activities"],"prefix":"10.1016","volume":"124","author":[{"given":"Xin-Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2019.170210_bib0005","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.neuron.2012.04.027","article-title":"Dichotomous organization of the external globus pallidus","volume":"74","author":"Mallet","year":"2012","journal-title":"Neuron."},{"key":"10.1016\/j.peptides.2019.170210_bib0010","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1523\/JNEUROSCI.4662-14.2015","article-title":"Prototypic and arkypallidal neurons in the dopamine-intact external globus pallidus","volume":"35","author":"Abdi","year":"2015","journal-title":"J. Neurosci."},{"issue":"34","key":"10.1016\/j.peptides.2019.170210_bib0015","doi-asserted-by":"crossref","first-page":"11830","DOI":"10.1523\/JNEUROSCI.4672-14.2015","article-title":"Parvalbumin+ neurons and Npas1+ neurons are distinct neuron classes in the mouse external globus pallidus","volume":"35","author":"Hern\u00e1ndez","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0020","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/ejn.13196","article-title":"The external globus pallidus: progress and perspectives","volume":"43","author":"Hegeman","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0025","first-page":"4219","article-title":"Classification of GABAergic neuron subtypes from the globus pallidus using wild-type and transgenic mice","volume":"596","author":"Abrahao","year":"2018","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.peptides.2019.170210_bib0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1152\/jn.1991.65.2.273","article-title":"Basal ganglia motor control. I. Nonexclusive relation of pallidal discharge to five movement modes","volume":"65","author":"Mink","year":"1991","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.peptides.2019.170210_bib0035","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0166-2236(96)10052-7","article-title":"Basal ganglia and movement disorders: an update","volume":"19","author":"Chesselet","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0040","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/23281","article-title":"A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus","volume":"400","author":"Plenz","year":"1999","journal-title":"Nature."},{"key":"10.1016\/j.peptides.2019.170210_bib0045","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nn.4559","article-title":"Cell-specific pallidal intervention induces long-lasting motor recovery in dopamine-depleted mice","volume":"20","author":"Mastro","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0050","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.1523\/JNEUROSCI.1720-15.2016","article-title":"Npas1+ pallidal neurons target striatal projection neurons","volume":"36","author":"Glajch","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0055","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/jnr.23889","article-title":"Altered membrane properties and firing patterns of external globus pallidus neurons in the R6\/2 mouse model of Huntington\u2019s disease","volume":"94","author":"Akopian","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0060","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-8993(94)90397-2","article-title":"The cortico-pallidal projection in the rat: an anterograde tracing study with biotinylated dextran amine","volume":"653","author":"Naito","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0065","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1074\/jbc.M212030200","article-title":"Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme","volume":"278","author":"Rioli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2019.170210_bib0070","doi-asserted-by":"crossref","first-page":"20588","DOI":"10.1073\/pnas.0706980105","article-title":"Hemopressin is an inverse agonist of CB1 cannabinoid receptors","volume":"104","author":"Heimann","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2019.170210_bib0075","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.neuroscience.2010.04.007","article-title":"Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats","volume":"168","author":"Sciolino","year":"2010","journal-title":"Neuroscience."},{"key":"10.1016\/j.peptides.2019.170210_bib0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drudis.2016.08.005","article-title":"Targeting the endocannabinoid system: future therapeutic strategies","volume":"22","author":"Aizpurua-Olaizola","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.peptides.2019.170210_bib0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/npp.2017.204","article-title":"The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain","volume":"43","author":"Donvito","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.peptides.2019.170210_bib0090","doi-asserted-by":"crossref","first-page":"20851","DOI":"10.1074\/jbc.M111.335273","article-title":"Cannabinoid receptors CB1 and CB2 form functional heteromers in brain","volume":"287","author":"Call\u00e9n","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2019.170210_bib0095","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2019.170210_bib0100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0105","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0306-4522(92)90409-U","article-title":"Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry","volume":"48","author":"Mailleux","year":"1992","journal-title":"Neuroscience."},{"key":"10.1016\/j.peptides.2019.170210_bib0110","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.neuroimage.2010.04.034","article-title":"Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR","volume":"52","author":"Wong","year":"2010","journal-title":"Neuroimage."},{"key":"10.1016\/j.peptides.2019.170210_bib0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881110367732","article-title":"Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis","volume":"25","author":"Lanciego","year":"2011","journal-title":"J Psychopharmacol."},{"key":"10.1016\/j.peptides.2019.170210_bib0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pnpbp.2014.02.012","article-title":"Strain differences in the expression of endocannabinoid genes and in cannabinoid receptor binding in the brain of Lewis and Fischer 344 rats","volume":"53","author":"Coria","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.peptides.2019.170210_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181064","article-title":"Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system","volume":"12","author":"Freundt-Revilla","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2019.170210_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191436","article-title":"The cannabinoid-1 receptor is abundantly expressed in striatal striosomes and striosome-dendron bouquets of the substantia nigra","volume":"13","author":"Davis","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2019.170210_bib0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0306-4522(03)00070-8","article-title":"Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia","volume":"119","author":"Julian","year":"2003","journal-title":"Neuroscience."},{"key":"10.1016\/j.peptides.2019.170210_bib0140","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1124\/jpet.105.092718","article-title":"Effects of exogenous and endogenous cannabinoids on GABAergic neurotransmission between the caudate-putamen and the globus pallidus in the mouse","volume":"316","author":"Engler","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2019.170210_bib0145","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.neuropharm.2016.08.002","article-title":"Cannabinoid-induced depression of synaptic transmission is switched to stimulation when dopaminergic tone is increased in the globus pallidus of the rodent","volume":"110","author":"Caballero-Flor\u00e1n","year":"2016","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.peptides.2019.170210_bib0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0014-2999(96)00111-2","article-title":"Electrophysiological effects of a cannabinoid on neural activity in the globus pallidus","volume":"304","author":"Miller","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2019.170210_bib0155","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuroscience.2005.01.058","article-title":"Cannabinoids depress excitatory neurotransmission between the subthalamic nucleus and the globus pallidus","volume":"133","author":"Freiman","year":"2005","journal-title":"Neuroscience."},{"key":"10.1016\/j.peptides.2019.170210_bib0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0014-2999(96)00326-3","article-title":"Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus","volume":"308","author":"Maneuf","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2019.170210_bib0165","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/syn.20778","article-title":"Regulation of subthalamic neuron activity by endocannabinoids","volume":"64","author":"Morera-Herreras","year":"2010","journal-title":"Synapse."},{"key":"10.1016\/j.peptides.2019.170210_bib0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/syn.20701","article-title":"Two opposite effects of Delta(9)-tetrahydrocannabinol on subthalamic nucleus neuron activity: involvement of GABAergic and glutamatergic neurotransmission","volume":"64","author":"Morera-Herreras","year":"2010","journal-title":"Synapse."},{"key":"10.1016\/j.peptides.2019.170210_bib0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jnc.14549","article-title":"Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity","volume":"147","author":"Mouro","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2019.170210_bib0180","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ana.410360406","article-title":"Selective vulnerability in Huntington\u2019s disease: preferential loss of cannabinoid receptors in lateral globus pallidus","volume":"36","author":"Richfield","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.peptides.2019.170210_bib0185","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington\u2019s disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington\u2019s disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience."},{"key":"10.1016\/j.peptides.2019.170210_bib0190","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0306-4522(03)00595-5","article-title":"Delayed onset of Huntington\u2019s disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors","volume":"123","author":"Glass","year":"2004","journal-title":"Neuroscience."},{"key":"10.1016\/j.peptides.2019.170210_bib0195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0006-8993(01)03403-5","article-title":"Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington\u2019s disease","volume":"929","author":"Lastres-Becker","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0200","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/10298420290030514","article-title":"Loss of cannabinoid CB(1) receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington\u2019s disease","volume":"4","author":"Lastres-Becker","year":"2002","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0205","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jchemneu.2009.02.001","article-title":"Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington\u2019s disease","volume":"37","author":"Allen","year":"2009","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.peptides.2019.170210_bib0210","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1016\/j.neurobiolaging.2014.06.010","article-title":"Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6\/2 Huntington mice","volume":"35","author":"Ooms","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.peptides.2019.170210_bib0215","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.expneurol.2011.03.014","article-title":"Metabolic and type 1 cannabinoid receptor imaging of a transgenic rat model in the early phase of Huntington disease","volume":"229","author":"Casteels","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.peptides.2019.170210_bib0220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/syn.10054","article-title":"Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington\u2019s disease","volume":"44","author":"Lastres-Becker","year":"2002","journal-title":"Synapse."},{"key":"10.1016\/j.peptides.2019.170210_bib0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076874","article-title":"Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats","volume":"8","author":"Chaves-Kirsten","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2019.170210_bib0230","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00702-003-0033-7","article-title":"Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain","volume":"110","author":"Hurley","year":"2003","journal-title":"J. Neural Transm. Vienna (Vienna)"},{"key":"10.1016\/j.peptides.2019.170210_bib0235","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/syn.21796","article-title":"Cannabinoid CB1 receptors activation and coactivation with D2 receptors modulate GABAergic neurotransmission in the globus pallidus and increase motor asymmetry","volume":"69","author":"Mu\u00f1oz-Arenas","year":"2015","journal-title":"Synapse."},{"key":"10.1016\/j.peptides.2019.170210_bib0240","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.neuropharm.2017.08.017","article-title":"GPR55: a therapeutic target for Parkinson\u2019s disease?","volume":"125","author":"Celorrio","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.peptides.2019.170210_bib0245","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.nbd.2018.06.019","article-title":"The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing\/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesia","volume":"118","author":"Rojo-Bustamante","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.peptides.2019.170210_bib0250","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/mds.10289","article-title":"Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson\u2019s disease","volume":"17","author":"Fox","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.peptides.2019.170210_bib0255","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1046\/j.1460-9568.2003.02896.x","article-title":"Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias","volume":"18","author":"Ferrer","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0260","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1600-0773.2003.930202.x","article-title":"The CB1 cannabinoid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxydopamine-lesioned rats","volume":"93","author":"Gilgun-Sherki","year":"2003","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.peptides.2019.170210_bib0265","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1096\/fj.04-3010fje","article-title":"A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson\u2019s disease","volume":"19","author":"van der Stelt","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.peptides.2019.170210_bib0270","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.expneurol.2014.05.004","article-title":"Prenatal poly I:C age-dependently alters cannabinoid type 1 receptors in offspring: a longitudinal small animal PET study using [(18)F]MK-9470","volume":"257","author":"Verdurand","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.peptides.2019.170210_bib0275","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pnpbp.2017.06.005","article-title":"Oral haloperidol or olanzapine intake produces distinct and region-specific increase in cannabinoid receptor levels that is prevented by high fat diet","volume":"79","author":"Delis","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.peptides.2019.170210_bib0280","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.neuropharm.2012.03.028","article-title":"Early exposure to ethanol differentially affects ethanol preference at adult age in two inbred mouse strains","volume":"63","author":"Molet","year":"2012","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.peptides.2019.170210_bib0285","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0006-8993(82)90260-8","article-title":"Dual topographic representation of neostriatum in the globus pallidus of rats","volume":"243","author":"Wilson","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0290","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0006-8993(88)91217-6","article-title":"Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study","volume":"460","author":"Gerfen","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0295","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1523\/JNEUROSCI.09-12-04439.1989","article-title":"Histochemical visualization of neutral endopeptidase-24.11 (enkephalinase) activity in rat brain: cellular localization and codistribution with enkephalins in the globus pallidus","volume":"9","author":"Back","year":"1989","journal-title":"J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0300","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0166-2236(90)90106-K","article-title":"The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neuroneh","volume":"13","author":"Smith","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0305","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1744-8069-4-41","article-title":"Differential regulation of morphine antinociceptive effects by endogenous enkephalinergic system in the forebrain of mice","volume":"4","author":"Chen","year":"2008","journal-title":"Mol. Pain"},{"key":"10.1016\/j.peptides.2019.170210_bib0310","doi-asserted-by":"crossref","first-page":"7028","DOI":"10.1073\/pnas.85.18.7028","article-title":"Vesicular localization of immunoreactive [Met5]enkephalin in the globus pallidus","volume":"85","author":"Coulter","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2019.170210_bib0315","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0006-8993(84)90261-0","article-title":"Evidence for the presynaptic localization of opiate binding sites on striatal efferent fibers","volume":"323","author":"Abou-Khalil","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0320","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/cne.903450104","article-title":"Expression of mu opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level","volume":"345","author":"Delfs","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.peptides.2019.170210_bib0325","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/cne.903500307","article-title":"Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study","volume":"350","author":"Mansour","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.peptides.2019.170210_bib0330","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0891-0618(94)00044-T","article-title":"Immunocytochemical localization of delta opioid receptors in mouse brain","volume":"8","author":"Bausch","year":"1995","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.peptides.2019.170210_bib0335","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0306-4522(98)00251-6","article-title":"Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study","volume":"88","author":"Peckys","year":"1999","journal-title":"Neuroscience."},{"key":"10.1016\/j.peptides.2019.170210_bib0340","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0006-8993(93)91021-J","article-title":"Alterations in delta opioid receptor levels in discrete areas of the neocortex and in the globus pallidus of the aging guinea pig: a quantitative autoradiographic study","volume":"614","author":"Hiller","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0345","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0361-9230(85)90090-5","article-title":"Effects of enkephalin and morphine on rat globus pallidus neurons","volume":"14","author":"Frey","year":"1985","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.peptides.2019.170210_bib0350","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0306-4522(85)90121-6","article-title":"Behavioural effects in rats of unilateral and bilateral injections of opiate receptor agonists into the globus pallidus","volume":"15","author":"Dewar","year":"1985","journal-title":"Neuroscience."},{"key":"10.1016\/j.peptides.2019.170210_bib0355","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/0006-2952(87)90062-1","article-title":"Effects of opioid agonist drugs on the in vitro release of 3H-GABA, 3H-dopamine and 3H-5HT from slices of rat globus pallidus","volume":"36","author":"Dewar","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.peptides.2019.170210_bib0360","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/exnr.1994.1007","article-title":"On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus","volume":"125","author":"Maneuf","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.peptides.2019.170210_bib0365","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1523\/JNEUROSCI.19-12-04796.1999","article-title":"Presynaptic mu and delta opioid receptor modulation of GABAA IPSCs in the rat globus pallidus in vitro","volume":"19","author":"Stanford","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0370","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/syn.10294","article-title":"Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response","volume":"51","author":"Spadoni","year":"2004","journal-title":"Synapse."},{"key":"10.1016\/j.peptides.2019.170210_bib0375","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0022-3565(24)37536-6","article-title":"Opioid regulation of pallidal enkephalin release: bimodal effects of locally administered mu and delta opioid agonists in freely moving rats","volume":"285","author":"Olive","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2019.170210_bib0380","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1471-4159.2011.07293.x","article-title":"Microdialysis and mass spectrometric monitoring of dopamine and enkephalins in the globus pallidus reveal reciprocal interactions that regulate movement","volume":"118","author":"Mabrouk","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2019.170210_bib0385","doi-asserted-by":"crossref","first-page":"36625","DOI":"10.1074\/jbc.M110.159954","article-title":"The dopamine D1-D2 receptor heteromer localizes in dynorphin\/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia","volume":"285","author":"Perreault","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2019.170210_bib0390","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1139\/y91-063","article-title":"The K(+)-evoked release of [3H]acetylcholine from slices of rat globus pallidus: modulation by delta-opioid receptors","volume":"69","author":"Ruzicka","year":"1991","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.peptides.2019.170210_bib0395","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1460-9568.2003.02767.x","article-title":"Enkephalin contributes to the locomotor stimulating effects of 3,4-methylenedioxy-N-methylamphetamine","volume":"18","author":"Compan","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0400","doi-asserted-by":"crossref","first-page":"17416","DOI":"10.1523\/JNEUROSCI.3087-11.2011","article-title":"An anxiolytic role for CRF receptor type 1 in the globus pallidus","volume":"31","author":"Sztainberg","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0405","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science."},{"key":"10.1016\/j.peptides.2019.170210_bib0410","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/j.1460-9568.1996.tb01318.x","article-title":"Bilateral 6-hydroxydopamine-induced lesion of the nigrostriatal dopamine pathway reproduces the effects of unilateral lesion on substance P but not on enkephalin expression in rat basal ganglia","volume":"8","author":"Salin","year":"1996","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0415","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0014-4886(95)90012-8","article-title":"Neurotoxicity induced by prenatal exposure to MPTP on the monoaminergic and peptidergic systems of the marmoset brain","volume":"131","author":"P\u00e9rez-Ota\u00f1o","year":"1995","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.peptides.2019.170210_bib0420","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1111\/ejn.12596","article-title":"The effect of striatal pre-enkephalin overexpression in the basal ganglia of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease","volume":"40","author":"Bissonnette","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0425","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0304-3940(91)90892-W","article-title":"Met-enkephalin immunoreactivity in the basal ganglia in symptomatic and asymptomatic MPTP-exposed monkeys: correlation with degree of parkinsonian symptoms","volume":"127","author":"Dacko","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.peptides.2019.170210_bib0430","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0014-4886(03)00050-5","article-title":"Enkephalin, neurotensin, and substance P immunoreactivite neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra","volume":"183","author":"Martorana","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.peptides.2019.170210_bib0435","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.expneurol.2004.05.041","article-title":"Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP","volume":"189","author":"Betarbet","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.peptides.2019.170210_bib0440","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.nbd.2013.10.016","article-title":"Abnormal structure-specific peptide transmission and processing in a primate model of Parkinson\u2019s disease and l-DOPA-induced dyskinesia","volume":"62","author":"Bourdenx","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.peptides.2019.170210_bib0445","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0006-8993(02)03010-X","article-title":"GABA(A) and mu-opioid receptor binding in the globus pallidus and endopeduncular nucleus of animals symptomatic for and recovered from experimental Parkinsonism","volume":"947","author":"Schroeder","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0450","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1046\/j.1471-4159.2002.01010.x","article-title":"GABA-opioid interactions in the globus pallidus: [D-Ala2]-Met-enkephalinamide attenuates potassium-evoked GABA release after nigrostriatal lesion","volume":"82","author":"Schroeder","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2019.170210_bib0455","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4522(94)00427-7","article-title":"Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington\u2019s disease using high resolution image analysis","volume":"64","author":"Sapp","year":"1995","journal-title":"Neuroscience."},{"key":"10.1016\/j.peptides.2019.170210_bib0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075099","article-title":"Striatal pre-enkephalin overexpression improves Huntington\u2019s disease symptoms in the R6\/2 mouse model of Huntington\u2019s disease","volume":"8","author":"Bissonnette","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2019.170210_bib0465","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1471-4159.1994.63020777.x","article-title":"Regulation of mu-opioid receptor mRNA in rat globus pallidus: effects of enkephalin increases induced by short- and long-term haloperidol administration","volume":"63","author":"Delfs","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2019.170210_bib0470","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s002130000460","article-title":"Decreased mu-opioid receptor binding in the globus pallidus of rats treated with chronic haloperidol","volume":"150","author":"Bower","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.peptides.2019.170210_bib0475","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0306-4522(02)00127-6","article-title":"Blockade of nigral and pallidal opioid receptors suppresses vacuous chewing movements in a rodent model of tardive dyskinesia","volume":"112","author":"McCormick","year":"2002","journal-title":"Neuroscience."},{"key":"10.1016\/j.peptides.2019.170210_bib0480","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11307-005-7001-6","article-title":"Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain","volume":"7","author":"Hietala","year":"2005","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.peptides.2019.170210_bib0485","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1111\/j.1460-9568.2006.04800.x","article-title":"Cellular and subcellular localization of neurokinin-1 and neurokinin-3 receptors in primate globus pallidus","volume":"23","author":"L\u00e9vesque","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0490","first-page":"58","article-title":"Neurokinin-1 receptor activation in globus pallidus","volume":"3","author":"Chen","year":"2009","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0495","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1007\/s00429-017-1453-8","article-title":"Substance P effects exclusively on prototypic neurons in mouse globus pallidus","volume":"222","author":"Mizutani","year":"2017","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.peptides.2019.170210_bib0500","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/j.1460-9568.2007.05803.x","article-title":"Substance P excites globus pallidus neurons in vivo","volume":"26","author":"Cui","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0505","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neures.2007.10.007","article-title":"Effects of substance P on neuronal firing of pallidal neurons in parkinsonian rats","volume":"60","author":"Cui","year":"2008","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0510","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neulet.2003.09.026","article-title":"Cytochrome oxidase activity in the monkey globus pallidus and subthalamic nucleus after ablation of striatal interneurons expressing substance P receptors","volume":"353","author":"Chiken","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.peptides.2019.170210_bib0515","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbr.2008.11.021","article-title":"Effects of substance P microinjections into the globus pallidus and central nucleus of amygdala on passive avoidance learning in rats","volume":"198","author":"Kertes","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0520","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbr.2010.06.027","article-title":"Positive reinforcing effects of substance P in the rat globus pallidus revealed by conditioned place preference","volume":"215","author":"Kertes","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0525","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(83)90403-1","article-title":"Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains","volume":"268","author":"Mauborgne","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0530","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0306-4522(94)90061-2","article-title":"Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson\u2019s disease patients","volume":"61","author":"Fernandez","year":"1994","journal-title":"Neuroscience."},{"key":"10.1016\/j.peptides.2019.170210_bib0535","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/j.1471-4159.1986.tb00793.x","article-title":"Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmoset","volume":"47","author":"Jenner","year":"1986","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2019.170210_bib0540","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0006-8993(89)90529-5","article-title":"Substance P-like immunoreactivity in brains with pathological features of Parkinson\u2019s and Alzheimer\u2019s diseases","volume":"486","author":"Clevens","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0545","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/cne.902570307","article-title":"Neurotensin in projection neurons of the striatum and nucleus accumbens, with reference to coexistence with enkephalin and GABA: an immunohistochemical study in the cat","volume":"257","author":"Sugimoto","year":"1987","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.peptides.2019.170210_bib0550","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0306-4522(96)00166-2","article-title":"Morphologically distinct subpopulations of neurotensin immunoreactive striatal neurons observed in rat following dopamine depletions and D2 receptor blockade project to the globus pallidus","volume":"74","author":"Brog","year":"1996","journal-title":"Neuroscience."},{"key":"10.1016\/j.peptides.2019.170210_bib0555","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/cne.903530108","article-title":"Distribution of neurotensin-containing neurons in the central nervous system of the dog","volume":"353","author":"Atoji","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.peptides.2019.170210_bib0560","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0028-3908(00)00060-5","article-title":"Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody","volume":"39","author":"Fassio","year":"2000","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.peptides.2019.170210_bib0565","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/syn.20306","article-title":"Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study","volume":"60","author":"Martorana","year":"2006","journal-title":"Synapse."},{"key":"10.1016\/j.peptides.2019.170210_bib0570","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.neuroscience.2004.02.031","article-title":"Neurotensin depolarizes globus pallidus neurons in rats via neurotensin type-1 receptor","volume":"125","author":"Chen","year":"2004","journal-title":"Neuroscience."},{"key":"10.1016\/j.peptides.2019.170210_bib0575","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.expneurol.2007.01.031","article-title":"Electrophysiological and behavioral effects of neurotensin in rat globus pallidus: an in vivo study","volume":"205","author":"Xue","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.peptides.2019.170210_bib0580","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2005.08.036","article-title":"Differential neurotensin responses to low and high doses of methamphetamine in the terminal regions of striatal efferents","volume":"522","author":"Frankel","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2019.170210_bib0585","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/jpet.113.205310","article-title":"Response of neurotensin basal ganglia systems during extinction of methamphetamine self-administration in rat","volume":"346","author":"Hanson","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2019.170210_bib0590","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/jnc.12727","article-title":"Mephedrone alters basal ganglia and limbic neurotensin systems","volume":"130","author":"German","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2019.170210_bib0595","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1471-4159.2011.07215.x","article-title":"Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment","volume":"117","author":"Alburges","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2019.170210_bib0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(94)90021-3","article-title":"Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat","volume":"262","author":"Castel","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2019.170210_bib0605","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0196-9781(85)90428-0","article-title":"Behavioral and biochemical assessment of time-related changes in globus pallidus and striatal dopamine induced by intranigrally administered neurotensin","volume":"6","author":"Napier","year":"1985","journal-title":"Peptides."},{"key":"10.1016\/j.peptides.2019.170210_bib0610","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1046\/j.1460-9568.1999.00506.x","article-title":"Blockade of neurotensin receptors suppresses the dopamine D1\/D2 synergism on immediate early gene expression in the rat brain","volume":"11","author":"Alonso","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0615","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/j.1460-9568.1997.tb00750.x","article-title":"Differential effects of intrastriatal neurotensin(1-13) and neurotensin(8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat","volume":"9","author":"Ferraro","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0620","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1523\/JNEUROSCI.18-17-06977.1998","article-title":"The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop","volume":"18","author":"Ferraro","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0625","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1460-9568.2011.07949.x","article-title":"Striatal NTS1, dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat","volume":"35","author":"Ferraro","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0630","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.neuroscience.2006.05.049","article-title":"Neurotensin selectively facilitates glutamatergic transmission in globus pallidus","volume":"141","author":"Chen","year":"2006","journal-title":"Neuroscience."},{"key":"10.1016\/j.peptides.2019.170210_bib0635","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/syn.21907","article-title":"Sex differences in neurotensin and substance P following nicotine self-administration in rats","volume":"70","author":"Pittenger","year":"2016","journal-title":"Synapse."},{"key":"10.1016\/j.peptides.2019.170210_bib0640","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0196-9781(94)00141-3","article-title":"Characterization of neurotensin-like immunoreactivity in human basal ganglia: increased neurotensin levels in substantia nigra in Parkinson\u2019s disease","volume":"16","author":"Fernandez","year":"1995","journal-title":"Peptides."},{"key":"10.1016\/j.peptides.2019.170210_bib0645","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0006-8993(89)90174-1","article-title":"Asymmetrical distribution of neurotensin immunoreactivity following unilateral injection of 6-hydroxydopamine in rat ventral tegmental area (VTA)","volume":"483","author":"Zahm","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0650","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000199047","article-title":"Electrophysiological effects of neurotensin on globus pallidus neurons of 6-hydroxydopamine-lesioned rats","volume":"17","author":"Xue","year":"2009","journal-title":"Neurosignals."},{"key":"10.1016\/j.peptides.2019.170210_bib0655","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12264-010-0518-y","article-title":"Effects of pallidal neurotensin on haloperidol-induced parkinsonian catalepsy: behavioral and electrophysiological studies","volume":"26","author":"Xue","year":"2010","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.peptides.2019.170210_bib0660","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0306-4522(03)00170-2","article-title":"Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia","volume":"119","author":"McCormick","year":"2003","journal-title":"Neuroscience."},{"key":"10.1016\/j.peptides.2019.170210_bib0665","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2019.170210_bib0670","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/cne.1190","article-title":"Differential expression of orexin receptors 1 and 2 in the rat brain","volume":"435","author":"Marcus","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.peptides.2019.170210_bib0675","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.bjp.0705610","article-title":"Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor","volume":"141","author":"Langmead","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2019.170210_bib0680","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell."},{"key":"10.1016\/j.peptides.2019.170210_bib0685","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/bph.12415","article-title":"The hypocretins\/orexins: integrators of multiple physiological functions","volume":"171","author":"Li","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2019.170210_bib0690","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neubiorev.2014.12.005","article-title":"Roles of the orexin system in central motor control","volume":"49","author":"Hu","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.peptides.2019.170210_bib0695","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0196-9781(99)00157-6","article-title":"Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord","volume":"20","author":"Cutler","year":"1999","journal-title":"Peptides."},{"key":"10.1016\/j.peptides.2019.170210_bib0700","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-8993(99)01336-0","article-title":"Distribution of orexin neurons in the adult rat brain","volume":"827","author":"Nambu","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0705","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00429-011-0343-8","article-title":"Orexinergic innervation of the extended amygdala and basal ganglia in the rat","volume":"217","author":"Schmitt","year":"2012","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.peptides.2019.170210_bib0710","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0306-4522(01)00033-1","article-title":"Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord","volume":"103","author":"Hervieu","year":"2001","journal-title":"Neuroscience."},{"key":"10.1016\/j.peptides.2019.170210_bib0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchemneu.2015.03.002","article-title":"Distribution of the orexin-1 receptor (OX1R) in the mouse forebrain and rostral brainstem: a characterisation of OX1R-eGFP mice","volume":"66-67","author":"Ch\u2019ng","year":"2015","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.peptides.2019.170210_bib0720","doi-asserted-by":"crossref","first-page":"E3735","DOI":"10.1073\/pnas.1412189111","article-title":"Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns","volume":"111","author":"Bergman","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.peptides.2019.170210_bib0725","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jns.2006.08.004","article-title":"CSF orexin levels of Parkinson\u2019s disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration","volume":"250","author":"Yasui","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.peptides.2019.170210_bib0730","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/brain\/awm090","article-title":"Hypocretin (orexin) loss in Parkinson\u2019s disease","volume":"130","author":"Fronczek","year":"2007","journal-title":"Brain."},{"key":"10.1016\/j.peptides.2019.170210_bib0735","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/brain\/awm097","article-title":"Hypocretin (orexin) cell loss in Parkinson\u2019s disease","volume":"130","author":"Thannickal","year":"2007","journal-title":"Brain."},{"key":"10.1016\/j.peptides.2019.170210_bib0740","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2869.2012.01027.x","article-title":"Progressive dopamine and hypocretin deficiencies in Parkinson\u2019s disease: is there an impact on sleep and wakefulness?","volume":"21","author":"Wienecke","year":"2012","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.peptides.2019.170210_bib0745","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1111\/ejn.13323","article-title":"Orexin-A increases the activity of globus pallidus neurons in both normal and parkinsonian rats","volume":"44","author":"Xue","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.peptides.2019.170210_bib0750","doi-asserted-by":"crossref","first-page":"C800","DOI":"10.1152\/ajpcell.00125.2019","article-title":"Orexins alleviate motor deficits via increasing firing activity of pallidal neurons in a mouse model of Parkinson\u2019s disease","volume":"317","author":"Wang","year":"2019","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"10.1016\/j.peptides.2019.170210_bib0755","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1152\/jn.00244.2012","article-title":"Presynaptic modulation by somatostatin in the rat neostriatum is altered in a model of parkinsonism","volume":"108","author":"L\u00f3pez-Huerta","year":"2012","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.peptides.2019.170210_bib0760","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1471-4159.1987.tb05748.x","article-title":"Evidence for somatostatin-containing fibers projecting from the pallidal complex to the striatum of the rat","volume":"48","author":"Widmann","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2019.170210_bib0765","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00213-008-1305-6","article-title":"Activation of somatostatin receptors in the globus pallidus increases rat locomotor activity and dopamine release in the striatum","volume":"201","author":"Marazioti","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.peptides.2019.170210_bib0770","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s12640-017-9841-7","article-title":"Alteration of the PAC1 Receptor Expression in the Basal Ganglia of MPTP-Induced Parkinsonian Macaque Monkeys","volume":"33","author":"Feher","year":"2018","journal-title":"Neurotox. Res."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119301883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119301883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:25:15Z","timestamp":1759310715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978119301883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":154,"alternative-id":["S0196978119301883"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2019.170210","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The globus pallidus as a target for neuropeptides and endocannabinoids participating in central activities","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2019.170210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170210"}}